Skip main navigation

Military Health System

Hurricane Milton & Hurricane Helene

Emergency procedures are in place in multiple states due to Hurricane Milton & Hurricane Helene. >>Learn More

Novavax COVID-19 Vaccine Now Available for 12 to 17 Year-Olds

Image of Novavax COVID-19 Vaccine Now Available for 12 to 17 Year-Olds. Novavax COVID-19 Vaccine Now Available for 12 to 17 Year-Olds

Adolescents ages 12 to 17 can now receive the Novavax COVID-19 vaccine, the fourth vaccine to be authorized for the prevention of coronavirus.

Similar to other vaccines on the market, the vaccination regimen for Novavax calls for two doses three weeks apart. 

Military Health System parents who are interested in the Novavax option for their children should contact their provider to discuss this vaccination option and for availability of the vaccine. The vaccine may also be available through TRICARE in-network pharmacies or other participating pharmacies.

The Centers for Disease Control and Prevention recommended the vaccine on Aug. 22 for use in adolescents ages 12 to 17 after the Food and Drug Administration gave emergency use authorization (EUA) for its use in that same age group on Aug. 19.

An EUA means the product has not been fully approved by FDA but is available during public health emergencies because clinical data have shown it to be safe and effective.

Novavax Already Authorized for Those 18 and Older

The FDA previously authorized Novavax on July 13 for use against COVID-19 in those 18 years and older. The CDC recommended the vaccine on July 19 for that same age group.

The Department of Defense and the Department of Health and Human Services secured 3.2 million doses of Novavax in June in advance of the decisions by the FDA and CDC.

Novavax is the Newest COVID-19 Vaccine

Novavax is the fourth COVID-19 vaccine to either get authorized or fully approved.

The FDA approved Pfizer and Moderna’s messenger RNA (mRNA) vaccines for primary doses. Those vaccines are also authorized for boosters.

Johnson & Johnson/Janssen’s one-dose modified adenovirus vaccine is still available in limited circumstances as a primary vaccine or booster for those 18 and older.

The CDC has a chart that shows you how your health provider should give each COVID-19 vaccine as a primary series or booster in different age groups and in those whose immune systems are weakened.

The Novavax COVID-19 vaccine is not currently authorized as a booster dose for any age group.

Novavax said it has been studying how well its vaccine will work as a booster, “and the vaccine has been included in studies assessing mixing and matching different vaccines.”

How Novavax is Different

Novavax’s protein-based virus blocking technology is based on a more traditional platform than the Pfizer and Moderna vaccines—the first mRNA vaccines to be allowed for use in the prevention of any infectious disease.

“The vaccine packages harmless proteins of the COVID-19 virus alongside another ingredient called an adjuvant that helps the immune system respond to the virus in the future,” the CDC explained. Protein-based vaccines have been used for more than 30 years in the United States.

“Novavax offers the latest tool to combat COVID-19, which means another option for military beneficiaries to get their COVID-19 vaccinations," said Air Force Lt. Col. Ruth Brenner, deputy chief of the Defense Health Agency Immunization Healthcare Division. "Because Novavax uses a vaccine platform that has been the basis of vaccines for 30 years, some beneficiaries may feel more comfortable using it for their protection against COVID-19."

Last May, the company started a large-scale clinical trial to test a booster that targets the Omicron variant. Novavax plans to speed up research on shots tailored to BA.4 and BA.5 subvariants, and it’s also working on a bivalent booster against the Omicron variant. Pfizer and Moderna expect their bivalent boosters against Omicron will be authorized soon.

You also may be interested in...

Publication
Apr 7, 2020

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

.PDF | 1.06 MB

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized ...

Publication
Apr 5, 2020

DoD Guidance on the Use of Cloth Face Coverings

.PDF | 1.02 MB

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Publication
Apr 2, 2020

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

.PDF | 457.94 KB

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future ...

Fact Sheet
Mar 24, 2020

Elective Surgery and Procedures Q & A

.PDF | 42.83 KB

Today, the Department issued guidance directing that all Military Medical Treatment Facilities (MTFs) and Dental Treatment Facilities (DTFs) postpone all elective surgeries, invasive procedures, and dental procedures as of March 31, 2020 for 60 days. This Fact Sheet answers commonly asked questions about that guidance.

Technical Document
Mar 24, 2020

DOD COVID-19 Practice Management Guide

.PDF | 2.89 MB

This COVID-19 Practice Management Guide has been rapidly and thoughtfully developed by a multi-specialty group of 60 subject matter experts from across the Department of Defense Military Health System. This Practice Management Guideline consolidates resources and optimizes the management of patients requiring clinical care during the global COVID-19 ...

Publication
Mar 19, 2020

COVID-19 Life Support Training Extension

.PDF | 361.65 KB

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Congressional Testimony
Mar 11, 2020

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform

.PDF | 109.27 KB

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform

Publication
Feb 25, 2020

Force Health Protection (Supplement 2) - Department of Defense Guidance for Military Installation Commanders' Risk-Based Measured Responses to the Novel Coronavirus Outbreak

.PDF | 2.06 MB

Novel coronavirus disease (COVID-19) continues to spread and is an increasing force health protection (FHP) threat in areas where Department of Defense (DoD) personnel live and work. As the leading U.S. Government public health agency, the U.S. Centers for Disease Control and Prevention (CDC) continues to assess the risk of COVID-19 and provide ...

Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery